Sagimet Biosciences revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SGMT annual revenue was $0.0, with -100% growth year-over-year.
SGMT past revenue growth
How has SGMT's revenue growth performed historically?
Sagimet Biosciences (NASDAQ: SGMT) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Sagimet Biosciences's revenue was $0.00.
What was Sagimet Biosciences's revenue in 2024?
Sagimet Biosciences's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a 100% decrease year over year.
How much does Sagimet Biosciences make in a day?
Based on Sagimet Biosciences annual revenue for the past three years, SGMT makes an average of $1,826.48 per day.
What was Sagimet Biosciences's annual revenue growth in the past year?
As of Q2 2025, Sagimet Biosciences's revenue has grown -100% year over year. This is 537.31 percentage points lower than the US Biotechnology industry revenue growth rate of 437.31%. Sagimet Biosciences's revenue in the past year totaled $0.00.
How much does Sagimet Biosciences make in a year?
Sagimet Biosciences's revenue by year for the past three years is:
Sagimet Biosciences's revenue for the twelve months ending Dec 31, 2024 was $0.00, a 100% decrease year over year.
Sagimet Biosciences's annual revenue for Dec 31, 2023 was $2.00 million, a Infinity% increase from 2022.
Sagimet Biosciences's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.